Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Walter Bock

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Biochemical Pharmacology|March 23, 2011
From differential induction of UDP-glucuronosyltransferases in rat liver to characterization of responsible ligand-activated transcription factors, and their multilevel crosstalk in humansKarl Walter Bock
Biochemical Pharmacology|June 29, 2016
From dioxin toxicity to putative physiologic functions of the human Ah receptor in homeostasis of stem/progenitor cellsKarl Walter Bock
Biochemical Pharmacology|May 12, 2010
Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levelsKarl Walter Bock
Biological Chemistry|February 2, 2013
The human Ah receptor: hints from dioxin toxicities to deregulated target genes and physiological functionsKarl Walter Bock
Biochemical Pharmacology|February 20, 2019
Aryl hydrocarbon receptor (AHR) functions in NAD<sup>+</sup> metabolism, myelopoiesis and obesityKarl Walter Bock
Biochemical Pharmacology|July 24, 2012
Human UDP-glucuronosyltransferases: feedback loops between substrates and ligands of their transcription factorsKarl Walter Bock
Biochemical Pharmacology|March 15, 2020
Modulation of aryl hydrocarbon receptor (AHR) and the NAD<sup>+</sup>-consuming enzyme CD38: Searches of therapeutic options for nonalcoholic fatty liver disease (NAFLD)Karl Walter Bock
Biochemical Pharmacology|June 19, 2023
Aryl hydrocarbon receptor (AHR): Towards understanding intestinal microbial ligands including vitamin B12 and folic acid as natural antagonistsKarl Walter Bock
Archives of Toxicology|April 8, 2017
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-mediated deregulation of myeloid and sebaceous gland stem/progenitor cell homeostasisKarl Walter Bock
Biochemical Pharmacology|August 30, 2019
Functions of aryl hydrocarbon receptor (AHR) and CD38 in NAD metabolism and nonalcoholic steatohepatitis (NASH)Karl Walter Bock
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Biochemical Pharmacology|March 23, 2011
From differential induction of UDP-glucuronosyltransferases in rat liver to characterization of responsible ligand-activated transcription factors, and their multilevel crosstalk in humansKarl Walter Bock
Biochemical Pharmacology|June 29, 2016
From dioxin toxicity to putative physiologic functions of the human Ah receptor in homeostasis of stem/progenitor cellsKarl Walter Bock
Biochemical Pharmacology|May 12, 2010
Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levelsKarl Walter Bock
Biological Chemistry|February 2, 2013
The human Ah receptor: hints from dioxin toxicities to deregulated target genes and physiological functionsKarl Walter Bock
Biochemical Pharmacology|February 20, 2019
Aryl hydrocarbon receptor (AHR) functions in NAD<sup>+</sup> metabolism, myelopoiesis and obesityKarl Walter Bock
Biochemical Pharmacology|July 24, 2012
Human UDP-glucuronosyltransferases: feedback loops between substrates and ligands of their transcription factorsKarl Walter Bock
Biochemical Pharmacology|March 15, 2020
Modulation of aryl hydrocarbon receptor (AHR) and the NAD<sup>+</sup>-consuming enzyme CD38: Searches of therapeutic options for nonalcoholic fatty liver disease (NAFLD)Karl Walter Bock
Biochemical Pharmacology|June 19, 2023
Aryl hydrocarbon receptor (AHR): Towards understanding intestinal microbial ligands including vitamin B12 and folic acid as natural antagonistsKarl Walter Bock
Archives of Toxicology|April 8, 2017
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-mediated deregulation of myeloid and sebaceous gland stem/progenitor cell homeostasisKarl Walter Bock
Biochemical Pharmacology|August 30, 2019
Functions of aryl hydrocarbon receptor (AHR) and CD38 in NAD metabolism and nonalcoholic steatohepatitis (NASH)Karl Walter Bock
Pageof 5